Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Reply to blood pressure target in chronic kidney disease.

Mancia G, Fagard R, Zanchetti A.

J Hypertens. 2013 Nov;31(11):2321-2. doi: 10.1097/HJH.0b013e328365a00a. No abstract available.

PMID:
24096262
[PubMed - in process]
2.

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS.

Ann Intern Med. 2005 Mar 1;142(5):342-51.

PMID:
15738453
[PubMed - indexed for MEDLINE]
3.

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.

Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, Foote C, Rodgers A, Zhang H, Wang H, Strippoli GF, Perkovic V.

CMAJ. 2013 Aug 6;185(11):949-57. doi: 10.1503/cmaj.121468. Epub 2013 Jun 24. Review.

PMID:
23798459
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group.

N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.

PMID:
20818902
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study.

Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun Oh J, Han SY, Young Lee E, Ki Kim D, Kim YS.

Hypertens Res. 2014 Feb;37(2):172-8. doi: 10.1038/hr.2013.127. Epub 2013 Sep 19.

PMID:
24048482
[PubMed - indexed for MEDLINE]
6.

Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.

Upadhyay A, Earley A, Haynes SM, Uhlig K.

Ann Intern Med. 2011 Apr 19;154(8):541-8. doi: 10.7326/0003-4819-154-8-201104190-00335. Epub 2011 Mar 14. Review.

PMID:
21403055
[PubMed - indexed for MEDLINE]
7.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5.

PMID:
24902920
[PubMed - in process]
8.

Blood pressure control in patients with chronic kidney disease.

Utsumi K, Katsura K, Iino Y, Katayama Y.

J Nippon Med Sch. 2012;79(2):111-4. Review.

PMID:
22687353
[PubMed - indexed for MEDLINE]
Free Article
9.

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.

Crews DC, Plantinga LC, Miller ER 3rd, Saran R, Hedgeman E, Saydah SH, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2010 May;55(5):1102-9. doi: 10.1161/HYPERTENSIONAHA.110.150722. Epub 2010 Mar 22.

PMID:
20308607
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.

Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2009 Jul;54(1):47-56. doi: 10.1161/HYPERTENSIONAHA.109.129841. Epub 2009 May 26.

PMID:
19470881
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease.

Ryu J, Cha RH, Kim DK, Lee JH, Yoon SA, Ryu DR, Oh JE, Kim S, Han SY, Lee EY, Kim YS; APrODiTe investigators.

J Korean Med Sci. 2014 Jul;29(7):957-64. doi: 10.3346/jkms.2014.29.7.957. Epub 2014 Jul 11.

PMID:
25045228
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Visit-to-visit variability of blood pressure and renal function decline in patients with diabetic chronic kidney disease.

Yokota K, Fukuda M, Matsui Y, Kario K, Kimura K.

J Clin Hypertens (Greenwich). 2014 May;16(5):362-6. doi: 10.1111/jch.12293. Epub 2014 Apr 8.

PMID:
24712921
[PubMed - indexed for MEDLINE]
13.

Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.

Rysavá R, Tesar V, Merta M; Czech Group for the Study of Glomerulonephritis.

Blood Press Monit. 2005 Aug;10(4):207-13.

PMID:
16077267
[PubMed - indexed for MEDLINE]
14.

Time for reflection predicts the progression of renal dysfunction in patients with nondiabetic chronic kidney disease.

Takenaka T, Mimura T, Kikuta T, Kato N, Inoue T, Kanno Y, Ohno Y, Kobayashi T, Miyawaki Y, Suzuki H.

Clin Exp Hypertens. 2009 May;31(3):220-30. doi: 10.1080/10641960902822476.

PMID:
19387898
[PubMed - indexed for MEDLINE]
15.

Strict blood-pressure control and progression of renal failure in children.

ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.

N Engl J Med. 2009 Oct 22;361(17):1639-50. doi: 10.1056/NEJMoa0902066.

PMID:
19846849
[PubMed - indexed for MEDLINE]
Free Article
16.

Hypertension and chronic kidney disease progression: why the suboptimal outcomes?

Bidani AK, Griffin KA, Epstein M.

Am J Med. 2012 Nov;125(11):1057-62. doi: 10.1016/j.amjmed.2012.04.008. Epub 2012 Aug 17. Review.

PMID:
22906957
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory.

Przybylowski P, Malyszko J, Malyszko JS, Kobus G, Sadowski J, Mysliwiec M.

Transplant Proc. 2010 Dec;42(10):4263-6. doi: 10.1016/j.transproceed.2010.09.025.

PMID:
21168679
[PubMed - indexed for MEDLINE]
18.

Hypertension awareness, treatment, and control in chronic kidney disease.

Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL.

Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025.

PMID:
18374693
[PubMed - indexed for MEDLINE]
19.

Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.

Małyszko J, Małyszko J, Bachórzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M.

Transplant Proc. 2009 Oct;41(8):3069-72. doi: 10.1016/j.transproceed.2009.07.078.

PMID:
19857679
[PubMed - indexed for MEDLINE]
20.

Nocturnal dosing and chronic kidney disease progression: new insights.

Goswami P, Drawz P, Rahman M.

Curr Opin Nephrol Hypertens. 2009 Sep;18(5):381-5. doi: 10.1097/MNH.0b013e32832f0032. Review.

PMID:
19593128
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk